Sign Up Today and Learn More About hC Bioscience Stock
Invest in or calculate the value of your shares in hC Bioscience or other pre-IPO companies through EquityZen's platform.
hC Bioscience Stock (HCCB)
HC Bioscience is an innovator and pioneer of protein editing using context agnostic engineered tRNA.
About hC Bioscience Stock
Founded
2021
Headquarters
Cambridge, MA, US
Industries
Science and Engineering, Health Care, Biotechnology
hC Bioscience Press Mentions
Stay in the know about the latest news on hC Bioscience
HC Bioscience, Inc.’s Post
linkedin • Aug 02, 2024
hC Bioscience Announces Program in Duchenne Muscular Dystrophy and Reports In Vivo Data From tRNA-based ...
finance • Jun 25, 2024
hC Bioscience Announces Program in Duchenne Muscular Dystrophy and Reports In Vivo Data From tRNA-based ...
biospace • Jun 24, 2024
Preclinical data support Hc Bioscience’s Duchenne muscular dystrophy program
bioworld • May 28, 2024
hC Bioscience Announces Lead Program in Hemophilia and Reports Positive Preclinical Data on Novel Protein Editing ...
finance • May 23, 2024
hC Bioscience Management
Leadership team at hC Bioscience
Board Member
David Moskowitz
Board of Director
Seiji Miyahara
Join now and verify your accreditation status to gain access to:
- hC Bioscience current valuation
- hC Bioscience stock price
- Available deals in hC Bioscience and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in hC Bioscience stock?
Accredited investors can buy pre-IPO stock in companies like hC Bioscience through EquityZen funds. These investments are made available by existing hC Bioscience shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell hC Bioscience stock?
Shareholders can sell their hC Bioscience stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
